LGND logo

LGND Total assets

annual total assets:

$941.77M+$154.56M(+19.63%)
December 31, 2024

Summary

  • As of today (September 14, 2025), LGND annual total assets is $941.77 million, with the most recent change of +$154.56 million (+19.63%) on December 31, 2024.
  • During the last 3 years, LGND annual total assets has fallen by -$355.82 million (-27.42%).
  • LGND annual total assets is now -37.00% below its all-time high of $1.49 billion, reached on December 31, 2019.

Performance

LGND Total assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLGNDbalance sheet metrics

quarterly total assets:

$948.60M+$43.17M(+4.77%)
June 30, 2025

Summary

  • As of today (September 14, 2025), LGND quarterly total assets is $948.60 million, with the most recent change of +$43.17 million (+4.77%) on June 30, 2025.
  • Over the past year, LGND quarterly total assets has increased by +$82.20 million (+9.49%).
  • LGND quarterly total assets is now -54.95% below its all-time high of $2.11 billion, reached on September 30, 2018.

Performance

LGND quarterly total assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLGNDbalance sheet metrics

Total assets Formula

Total Assets = Current Assets + Non-Current Assets

LGND Total assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+19.6%+9.5%
3 y3 years-27.4%-11.9%
5 y5 years-37.0%-23.7%

LGND Total assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-27.4%+23.5%-11.9%+25.1%
5 y5-year-37.0%+23.5%-30.4%+25.1%
alltimeall time-37.0%+1916.8%-55.0%+2535.0%

LGND Total assets History

DateAnnualQuarterly
Jun 2025
-
$948.60M(+4.8%)
Mar 2025
-
$905.43M(-3.9%)
Dec 2024
$941.77M(+19.6%)
$941.77M(-1.4%)
Sep 2024
-
$954.87M(+10.2%)
Jun 2024
-
$866.40M(-5.2%)
Mar 2024
-
$913.87M(+16.1%)
Dec 2023
$787.22M(+3.2%)
$787.22M(+2.3%)
Sep 2023
-
$769.23M(+1.5%)
Jun 2023
-
$758.11M(-6.5%)
Mar 2023
-
$811.08M(+6.3%)
Dec 2022
$762.67M(-41.2%)
$762.67M(-27.4%)
Sep 2022
-
$1.05B(-2.4%)
Jun 2022
-
$1.08B(-2.6%)
Mar 2022
-
$1.11B(-14.8%)
Dec 2021
$1.30B(-4.7%)
$1.30B(+1.9%)
Sep 2021
-
$1.27B(+1.4%)
Jun 2021
-
$1.26B(-3.0%)
Mar 2021
-
$1.30B(-4.9%)
Dec 2020
$1.36B(-8.9%)
$1.36B(+9.2%)
Sep 2020
-
$1.25B(+0.4%)
Jun 2020
-
$1.24B(+4.8%)
Mar 2020
-
$1.19B(-20.7%)
Dec 2019
$1.49B(+13.9%)
$1.49B(-3.4%)
Sep 2019
-
$1.55B(-14.1%)
Jun 2019
-
$1.80B(-5.9%)
Mar 2019
-
$1.91B(+45.8%)
Dec 2018
$1.31B(+81.7%)
$1.31B(-37.7%)
Sep 2018
-
$2.11B(+13.3%)
Jun 2018
-
$1.86B(+146.2%)
Mar 2018
-
$754.67M(+4.4%)
Dec 2017
$722.65M(+20.1%)
$722.65M(+9.1%)
Sep 2017
-
$662.34M(+3.5%)
Jun 2017
-
$640.02M(+1.6%)
Mar 2017
-
$629.72M(+4.7%)
Dec 2016
$601.59M(+19.6%)
$601.59M(+0.1%)
Sep 2016
-
$600.87M(+2.0%)
Jun 2016
-
$589.32M(+0.6%)
Mar 2016
-
$585.96M(+16.5%)
Dec 2015
$503.06M(+95.0%)
$503.06M(-3.6%)
Sep 2015
-
$521.70M(+71.2%)
Jun 2015
-
$304.76M(+15.8%)
Mar 2015
-
$263.22M(+2.0%)
Dec 2014
$258.03M(+146.4%)
$258.03M(-5.2%)
Sep 2014
-
$272.28M(+172.7%)
Jun 2014
-
$99.85M(-5.3%)
Mar 2014
-
$105.47M(+0.7%)
Dec 2013
$104.71M(+0.4%)
$104.71M(+3.0%)
Sep 2013
-
$101.68M(+2.1%)
Jun 2013
-
$99.57M(+1.2%)
Mar 2013
-
$98.36M(-5.7%)
Dec 2012
$104.26M(-13.5%)
$104.26M(+6.9%)
Sep 2012
-
$97.51M(-6.8%)
Jun 2012
-
$104.59M(-6.4%)
Mar 2012
-
$111.80M(-7.3%)
Dec 2011
$120.58M(+59.6%)
$120.58M(-1.5%)
Sep 2011
-
$122.47M(-4.3%)
Jun 2011
-
$127.98M(-5.0%)
Mar 2011
-
$134.69M(+78.3%)
Dec 2010
$75.56M(-46.7%)
$75.56M(-13.6%)
Sep 2010
-
$87.50M(-14.7%)
Jun 2010
-
$102.53M(-23.3%)
Mar 2010
-
$133.62M(-5.8%)
Dec 2009
$141.81M
$141.81M(+21.1%)
DateAnnualQuarterly
Sep 2009
-
$117.09M(-9.4%)
Jun 2009
-
$129.18M(-7.5%)
Mar 2009
-
$139.59M(-18.6%)
Dec 2008
$171.45M(-1.1%)
$171.45M(+16.5%)
Sep 2008
-
$147.19M(-8.0%)
Jun 2008
-
$160.02M(-3.8%)
Mar 2008
-
$166.26M(-4.0%)
Dec 2007
$173.28M(-46.9%)
$173.28M(-18.1%)
Sep 2007
-
$211.52M(-7.4%)
Jun 2007
-
$228.48M(-56.5%)
Mar 2007
-
$524.81M(+61.0%)
Dec 2006
$326.05M(+3.6%)
$326.05M(+40.6%)
Sep 2006
-
$231.87M(-18.9%)
Jun 2006
-
$285.93M(-1.0%)
Mar 2006
-
$288.69M(-8.2%)
Dec 2005
$314.62M(-5.4%)
$314.62M(+2.8%)
Sep 2005
-
$306.05M(+1.4%)
Jun 2005
-
$301.72M(-3.7%)
Mar 2005
-
$313.25M(-5.8%)
Dec 2004
$332.47M(+10.4%)
$332.47M(+15.2%)
Sep 2004
-
$288.66M(+1.2%)
Jun 2004
-
$285.32M(-3.0%)
Mar 2004
-
$294.19M(-2.3%)
Dec 2003
$301.25M(+11.3%)
$301.25M(+10.4%)
Sep 2003
-
$272.80M(+20.2%)
Jun 2003
-
$226.93M(-5.9%)
Mar 2003
-
$241.18M(-10.9%)
Dec 2002
$270.61M(+130.4%)
$270.61M(+129.3%)
Sep 2002
-
$118.03M(-7.5%)
Jun 2002
-
$127.66M(+7.4%)
Mar 2002
-
$118.91M(+1.2%)
Dec 2001
$117.47M(+3.6%)
$117.47M(+0.4%)
Sep 2001
-
$116.96M(-6.2%)
Jun 2001
-
$124.70M(-1.2%)
Mar 2001
-
$126.22M(+11.3%)
Dec 2000
$113.42M(-15.8%)
$113.42M(-1.4%)
Sep 2000
-
$115.01M(-10.8%)
Jun 2000
-
$128.99M(-0.4%)
Mar 2000
-
$129.56M(-3.8%)
Dec 1999
$134.65M(-13.7%)
$134.65M(+2.2%)
Sep 1999
-
$131.71M(+6.8%)
Jun 1999
-
$123.30M(-8.9%)
Mar 1999
-
$135.33M(-13.3%)
Dec 1998
$156.02M(+45.2%)
$156.02M(+24.1%)
Sep 1998
-
$125.74M(+52.8%)
Jun 1998
-
$82.27M(-8.0%)
Mar 1998
-
$89.45M(-16.7%)
Dec 1997
$107.42M(+2.7%)
$107.40M(+37.9%)
Sep 1997
-
$77.90M(-11.3%)
Jun 1997
-
$87.80M(-8.5%)
Mar 1997
-
$96.00M(-6.0%)
Dec 1996
$104.59M(+6.6%)
$102.10M(+51.0%)
Sep 1996
-
$67.60M(-11.9%)
Jun 1996
-
$76.70M(-10.4%)
Mar 1996
-
$85.60M(-8.5%)
Dec 1995
$98.12M(+110.1%)
$93.60M(+0.4%)
Sep 1995
-
$93.20M(+106.2%)
Mar 1995
-
$45.20M(-3.2%)
Dec 1994
$46.70M(-8.1%)
$46.70M(-10.4%)
Sep 1994
-
$52.10M(+44.7%)
Jun 1994
-
$36.00M(-16.7%)
Mar 1994
-
$43.20M
Dec 1993
$50.79M(-18.4%)
-
Dec 1992
$62.26M
-

FAQ

  • What is Ligand Pharmaceuticals Incorporated annual total assets?
  • What is the all time high annual total assets for Ligand Pharmaceuticals Incorporated?
  • What is Ligand Pharmaceuticals Incorporated annual total assets year-on-year change?
  • What is Ligand Pharmaceuticals Incorporated quarterly total assets?
  • What is the all time high quarterly total assets for Ligand Pharmaceuticals Incorporated?
  • What is Ligand Pharmaceuticals Incorporated quarterly total assets year-on-year change?

What is Ligand Pharmaceuticals Incorporated annual total assets?

The current annual total assets of LGND is $941.77M

What is the all time high annual total assets for Ligand Pharmaceuticals Incorporated?

Ligand Pharmaceuticals Incorporated all-time high annual total assets is $1.49B

What is Ligand Pharmaceuticals Incorporated annual total assets year-on-year change?

Over the past year, LGND annual total assets has changed by +$154.56M (+19.63%)

What is Ligand Pharmaceuticals Incorporated quarterly total assets?

The current quarterly total assets of LGND is $948.60M

What is the all time high quarterly total assets for Ligand Pharmaceuticals Incorporated?

Ligand Pharmaceuticals Incorporated all-time high quarterly total assets is $2.11B

What is Ligand Pharmaceuticals Incorporated quarterly total assets year-on-year change?

Over the past year, LGND quarterly total assets has changed by +$82.20M (+9.49%)
On this page